Who holds NVAXNOVAVAX
9 funds on our shelf carry NOVAVAX — heaviest hand: PBE at 3.13% of its book.
| Fund | Weight | Fund assets | Shares held | |
|---|---|---|---|---|
| PBEInvesco Biotechnology & Genome ETF | ACTIVE | 3.13% | $419M | 1,245,901 |
| IDNAiShares Genomics Immunology and Healthcare ETF | INDEX | 1.45% | $282M | 428,861 |
| XBIState Street SPDR S&P Biotech ETF | INDEX | 0.66% | $11B | 7,501,632 |
| IBBiShares Biotechnology ETF | INDEX | 0.12% | $10.7B | 1,190,323 |
| IBBQInvesco Nasdaq Biotechnology ETF | INDEX | 0.12% | $102M | 11,718 |
| IWNiShares Russell 2000 Value ETF | INDEX | 0.10% | $14.2B | 1,442,358 |
| VTWVVanguard Russell 2000 Value ETF | INDEX | 0.09% | $813M | 143,356 |
| TECBiShares U.S. Tech Breakthrough Multisector ETF | INDEX | 0.03% | $525M | 15,231 |
| VHTVanguard Health Care Index Fund | INDEX | 0.02% | $19B | 427,310 |
LATEST DISCLOSED BOOKS ON THE ENRICHED SHELF · THE SHELF GROWS NIGHTLY AS READERS RESEARCH NEW FUNDS